Neurotech International (ASX:NTI) Total Equity : A$11.90 Mil (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Neurotech International Total Equity?

Neurotech International's total equity for the quarter that ended in Jun. 2024 was A$11.90 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Neurotech International Total Equity Historical Data

The historical data trend for Neurotech International's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International Total Equity Chart

Neurotech International Annual Data

Trend

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Equity

Get a 7-Day Free Trial

-0.65

3.86

1.43

3.96

11.90

Neurotech International Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Equity	Get a 7-Day Free Trial											1.43	8.55	3.96	4.80	11.90

Neurotech International Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Neurotech International's Total Equity for the fiscal year that ended in Jun. 2024 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2024 )	-	Total Liabilities(Q: Jun. 2024 )
	=	12.213	-	0.315
	=	11.90

Neurotech International's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity	=	Total Assets(Q: Jun. 2024 )	-	Total Liabilities(Q: Jun. 2024 )
	=	12.213	-	0.315
	=	11.90

Neurotech International Total Equity Related Terms

Thank you for viewing the detailed overview of Neurotech International's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurotech International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » Total Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.neurotechinternational.com

Neurotech International Ltd is a medical device and solutions company conducting clinical studies to assess the neuroprotective, anti-inflammatory, and neuro-modulatory activities of its proprietary cannabis strains. Geographically, all the firm's business activities function through the region of Australia. It operates in one segment: Medical Device Development and Distribution.

Neurotech International Headlines

From GuruFocus

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend • 08-17-2013

9 Stocks with Double-Digit Yields and Buy or Better Recommendations

By Dividend Dividend • 07-17-2013

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend • 11-12-2014

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend • 01-17-2013

18 Stocks with Very High Yields (More Than 10%) and Earnings Growth

By Dividend Dividend • 12-20-2012

By Dividend Dividend • 06-25-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson • 11-09-2013